Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lutz

Showing results (331-340 of 346) with videos related to

Pageof 35
Sort By:
The Review of Scientific Instruments|September 22, 2023
Full aperture backscatter diagnostics for characterization of laser plasma instabilities at the extreme light infrastructure (ELI) beamlinesF Wasser, Ş Zähter, M Sokol, et al.
Bone Marrow Transplantation|June 28, 2016
Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really mattersD Bresters, A Lawitschka, C Cugno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal GroupManfred P Lutz, Eric Van Cutsem, Theo Wagener, et al.
Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinomaManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2017
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancerManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
British Journal of Cancer|October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessmentU Thiel, E Koscielniak, F Blaeschke, et al.
Pediatric Hematology and Oncology|December 15, 2016
Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelinesE Seror, J Donadieu, H Pacquement, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancerManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Pageof 35

Showing results (331-340 of 346) with videos related to

Sort By:
Pageof 35
The Review of Scientific Instruments|September 22, 2023
Full aperture backscatter diagnostics for characterization of laser plasma instabilities at the extreme light infrastructure (ELI) beamlinesF Wasser, Ş Zähter, M Sokol, et al.
Bone Marrow Transplantation|June 28, 2016
Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really mattersD Bresters, A Lawitschka, C Cugno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal GroupManfred P Lutz, Eric Van Cutsem, Theo Wagener, et al.
Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinomaManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2017
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancerManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
British Journal of Cancer|October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessmentU Thiel, E Koscielniak, F Blaeschke, et al.
Pediatric Hematology and Oncology|December 15, 2016
Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelinesE Seror, J Donadieu, H Pacquement, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancerManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Pageof 35